Psychiatric Times

Psychiatric Times is a news website focused on reporting the latest developments in psychiatry, with a particular emphasis on treatments and medications. The site covers various topics related to mental health, including new research findings, case studies, and expert opinions. While the site generally provides balanced reporting on the benefits and risks of different treatments, some articles may contain biases or deceptive practices due to the sensitive nature of the subject matter.

71%

The Daily's Verdict

This news site has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on its reporting.

Bias

75%

Examples:

  • Some articles may contain biases related to specific treatments or medications due to the nature of the content.
  • The site often reports on psychiatric treatments and medications, sometimes highlighting potential risks or complications.

Conflicts of Interest

85%

Examples:

  • Some authors may have ties to pharmaceutical companies, but this is disclosed in the articles.
  • The site occasionally covers studies or research involving pharmaceutical companies and their products. However, it does not seem to favor any particular company consistently.

Contradictions

100%

Examples:

  • No major contradictions found in the articles.

Deceptions

45%

Examples:

  • Articles discussing the potential risks of certain medications sometimes focus on sensational cases, which might give readers an exaggerated impression of the risks involved.
  • Some articles may use misleading headlines or present information in a way that could be confusing.

Recent Articles

  • AI Therapy: How Flint Offers Personalized Insights and Round-the-Clock Support for Mental Health

    AI Therapy: How Flint Offers Personalized Insights and Round-the-Clock Support for Mental Health

    Broke On: Wednesday, 15 May 2024 AI therapy apps like Flint offer personalized mental health support through virtual assistants, providing round-the-clock assistance and tailored insights for mood tracking, emotional resonance, and personal growth. While some prefer human interaction, the convenience and accessibility of AI therapy make it a valuable resource for those seeking affordable and accessible mental health solutions.
  • GLP-1 Receptor Agonists and Psychiatric Issues: Two Cases of Depression and Suicidal Ideation Linked to Semaglutide

    GLP-1 Receptor Agonists and Psychiatric Issues: Two Cases of Depression and Suicidal Ideation Linked to Semaglutide

    Broke On: Wednesday, 08 May 2024 Two case studies presented at the American Psychiatric Association annual meeting suggest a potential link between GLP-1 receptor agonists like semaglutide and psychiatric issues, including depression and suicidal ideation. The medication, which acts on the brain to modulate food intake and reward, has been associated with approximately 60 reported cases of suicidal ideation since 2018. Further research is needed to identify specific proteins or enzymes that may exacerbate psychological conditions and contribute to these risks.